Menstrual Cycle Metrics as a Digital Biomarker

Cycle length and its variability are the best characterised women's health measures in digital data, and almost all of that data is self reported rather than sensed.

Status
Exploratory
Unit
days
Data type
Duration
Sensor
User logging plus wearable physiology
Worn
Wrist

Evidence maturity

Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.

Verification
Emerging
Analytical validation
Emerging
Clinical validation
Limited

Characterised at a scale no clinical study has matched, which corrected the textbook picture of cycle length. The data is predominantly self reported, from a skewed user population, with definitions that vary between sources.

What are Menstrual Cycle Metrics

Menstrual cycle metrics describe the timing and pattern of the cycle: length from the first day of one period to the first day of the next, variability of that length between cycles, and the duration and pattern of bleeding.

Digital data has genuinely changed what is known here. Analyses of hundreds of thousands of cycles logged in apps have shown that cycle length is more variable between individuals, and within individuals, than the textbook twenty eight days implies, and that the classical figure describes fewer people than assumed. Global cohorts using mobile apps have replicated that picture.

An important honesty point sits at the centre of this page: these are self reported measures with a digital delivery mechanism, not sensor measurements. The app records what the user logs. That is still a large advance over recall at a clinic visit, but it is a different kind of evidence from the passively sensed measures elsewhere in this library.

How it is measured

The primary input is user logging of bleeding days, from which cycle length, variability and bleeding duration are computed. Increasingly this is combined with passively sensed physiology from a wearable, including resting heart rate, heart rate variability and skin temperature, which vary systematically across the cycle and can support or correct the logged dates.

Work characterising the cycle through a wearable device has described those physiological changes and their relationship to cycle phase, and methodological work has applied statistical models to label self tracked records and handle the missing and irregular data that self logging produces.

Data quality is the recurring issue. Logging is voluntary and incomplete, users start and stop, and a missed log is indistinguishable from a missed period unless the physiological data disambiguates it.

Clinical use

Two uses are defensible in research. The first is as an outcome in trials for menstrual disorders, endometriosis, polycystic ovary syndrome and contraceptive tolerability, where cycle characteristics are the thing being changed.

The second, and the one that applies far more widely, is as a covariate. Any wearable study enrolling premenopausal participants is measuring people whose heart rate, temperature and sleep shift with cycle phase. Treating that as noise costs statistical power, and the cost is invisible because the variance simply looks like scatter.

These measures have no counterpart in this library's instrument collection. Cycle specific patient reported instruments are a recognised gap, and rather than substitute a loosely related scale, the page states the absence.

Regulatory status

No regulatory qualification as an endpoint. Cycle tracking features are wellness functions and are not cleared for contraception, conception or diagnosis.

Limitations

Self report is the core limitation and it is not fixable by better sensors alone. App populations skew towards younger, more affluent, more health engaged users, which limits generalisation, and logging drops off over time in a way that is not random.

Hormonal contraception changes or abolishes the cycle, so a large proportion of the population of interest cannot be characterised by these measures at all, and studies that do not record contraceptive use will mix two different physiologies.

Definitions also vary. Whether spotting counts as bleeding, how cycles are bounded and what counts as irregular differ between studies and between apps, so figures are not directly comparable. And because the data is intimate and can reveal pregnancy, pregnancy loss and contraceptive use, consent and data governance obligations are heavier here than for most measures in this library.

References

  • Bull JR, et al. Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles. NPJ Digit Med. 2019. pubmed.ncbi.nlm.nih.gov
  • Grieger JA, Norman RJ. Menstrual cycle length and patterns in a global cohort of women using a mobile phone app. J Med Internet Res. 2020. pubmed.ncbi.nlm.nih.gov
  • Symul L, et al. Assessment of menstrual health status and evolution through mobile apps for fertility awareness. NPJ Digit Med. 2019. pubmed.ncbi.nlm.nih.gov
  • Gonzalez A, et al. The menstrual cycle through the lens of a wearable device: insights into physiology, sleep, and cycle variability. NPJ Digit Med. 2026. pubmed.ncbi.nlm.nih.gov
Related instruments

No cycle specific instrument exists in this library, which is a recognised gap rather than an oversight. Cycle data is otherwise captured by diary, and diary recall is the weakness these measures address.

Use case
Monitoring
Run women's health studies with WeGuide, the all in one patient engagement platform
Capture cycle data alongside wearable physiology and patient reported outcomes in a single workflow.

Collect your digital biomarker data in no time all under your own brand

Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.

Learn More

Connect your Data Sources

Connect wearables, smartphones, and digital health devices to collect relevant biomarker data directly from your patients.
Learn More
We Guide

Collect Data Continuously

Capture passive and active digital biomarker data such as activity, sleep, heart rate, mobility, and other vital signals over time.
Learn More

Collect the Data that Matters

Collect the digital health data most relevant to your research or clinical program. Choose the measurements and data points that support your specific study objectives and use case.
Learn More

Monitor the Full Patient Journey

Collect longitudinal biomarker data throughout the patient journey, from onboarding and baseline assessment to ongoing monitoring and follow up.
Learn More
Build your own biomarker, gather
evidence and commerclise
support screenshot
Pallete Paints

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient reported forms and clinical tests to remote wearables using our intuitive, centralised platform.
Clinical Trial Builder

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.
We Guide
We Guide
Toggle Right

Evaluate clinical algorithms instantly with AI powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.
We Guide

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.